Atara Bio
One of our clients at Roher/Sprague Partners is a bioetechnology company that works with creating Off‑the‑Shelf, Allogeneic T‑Cell Immunotherapies.
New Website for 2020
In 2019, we worked with a number of other vendors to build a new website for Atara Bio. It started with the head of communications wanting to update the design, remove the stock art, and make the site more mobile friendly. He also wanted to change investor platforms to Equisolve as Atara was unhappy with the previous investor site platform. Since the investor site was on a propietary platform while the public site was on a Wordpress based platform, the design and navigation often conflicted. For example, menu changes would not sync to all sections.
Equisolve started with a design of the new public site and investor site. Once that was almost ready, I took over with a few minor changes to improve the mobile site usability before we started building the new Wordpress theme and templates code. We hired some developers to help with the coding under my direction.
The new site makes use of a lot of new photography done by Atara during 2019. Since Atara is on the west coast in California, I was not able to do the photography, but provided composoition direction for the Atara team that was involved with the shooting.
The public site has a lot of links to the Equisolve investor site where stock info and press releases are pulled from JSON feeds. We also added an automatic display of the latest Atara Bio twitter posts. We intended to do the same with LinkedIn posts, but LinkedIn's policy changes caused that to be impossible in the end.
The original hamburger menu design for the mobile site was unacceptable for a smartphone user interface in this day, so I created a bottom-edge menu navigaton bar. The advantages here are that users can actually reach the navigation menu with one hand while holding a phone, and the navigation menu is much more obvious since it's spelled out in plain english as opposed to a cryptic icon that no one understands.
I also had to sneak in some modern CSS tweaks to for the mobile site design. First of all, the navigation bottom bar uses the backdrop filter attribute to cause a transparent acrylic-style blurry effect that shows the colors of the layers below as you scroll. Secondly, I added support for the prefers-color-scheme media query which allows the bottom navigation bar to alter itself based on the theme color preference of the user's browser.
For example, if you use an iPhone with the light-mode theme, the navigation bar will match the color and transparency effects of the Safari web browser. If you switch to a dark-mode theme, again, the websites navigation bar will match accordingly.
Of course, I'm big on graceful degredation in my website designs, so all of those new backdrop filter and color scheme CSS features have fall-backs... AND, I even added CSS support for emerging market KaiOS smartphones. In the medical fields, Internet Explorer still has a significant amount of market share as well, so we were sure to make the site functional there as well, though obviously it's a bit nicer on newer web browsers.
Updates
Throughout post launch, I also directed site updates such as integrating a job search that interfaces with ICIMS as well as an info request form and plenty of other content updates.
In 2023, new leadership requested a re-design of the site which featured a dark grey and yellow theme. The design was initiated by Real Chemistry for a few pages and then other pages were designed and developed by Roher/Sprague partners. This design removed the bottom-edge mobile navigation menu featured in the 2020 design which caused mobile traffic to reduce by about 20%, as expected.
Extranet
We also did some design work in partnership with Atara's sharepoint customization firm to develop Atara's new "AtaraNet" extranet site. We can't show that publicly though.
Social
We've been creating lots of featured graphics for Atara's Twitter and LinkedIn accounts to promote different news and events. Most were static images, but a number were video animations created in Adobe AfterEffects.
.@ASH_hematology kicks off today and Atara is joining! If you're registered, stop by our booth onsite or visit us virtually to learn more about Atara's mission to transform the lives of patients with serious diseases: https://t.co/iBUnVoJyyU. #ATARAASH2021 #ASH21 pic.twitter.com/gzF6bicJIO
— Atara Bio (@Atarabio) December 11, 2021
#DYK that ~90% of adults have been infected with #EBV at some point in their lives? Research shows that in approx. half of #PTLD patients, EBV is the cause of the disease. At #ASH21, we’ll share results from our ALLELE study of investigational tab-cel® for EBV+ #PTLD. pic.twitter.com/C6cLBw9tpU
— Atara Bio (@Atarabio) December 9, 2021
Atara’s EBV T-cell platform has the potential to address a wide range of EBV-driven diseases or other serious diseases through the incorporation of engineered #CARs. Learn more about our versatile platform: https://t.co/sZvAtSNIl1 pic.twitter.com/Rt347LrLjt
— Atara Bio (@Atarabio) October 18, 2023
While autologous T-cell therapies have been life-changing for many patients, allogeneic approaches hold the promise of personalized, off-the-shelf treatments manufactured at scale, stored and ready for rapid delivery. Learn more about Atara’s approach: https://t.co/sZvAtSNIl1 pic.twitter.com/6JIe0Z4mse
— Atara Bio (@Atarabio) October 23, 2023
At Atara, we are using allogeneic Epstein-Barr virus (#EBV) T cells as a platform to develop investigational therapies for cancer and autoimmune diseases. Learn more about our pipeline: https://t.co/9yUTxWY4Wx pic.twitter.com/Oo7z9VrlYs
— Atara Bio (@Atarabio) October 6, 2023
Today we observe World Lymphoma Awareness Day, aimed at increasing understanding of lymphomas such as #PTLD. We are working to address a significant unmet need for the countless lives affected by lymphomas around the world. #WLAD2023 pic.twitter.com/V7DD2hV4hb
— Atara Bio (@Atarabio) September 15, 2023
During #BloodCancerAwarenessMonth we stand with patients, survivors, and their families and honor those who succumbed to cancer. We’re dedicated to amplifying the voices of our #PTLD advocates, who inspire our work. Read their stories: https://t.co/4lOTKvrF3a pic.twitter.com/il72eUk7wo
— Atara Bio (@Atarabio) September 5, 2023